Related Experiment Video

Updated: Jul 7, 2026

Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans
08:24

Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans

Published on: February 27, 2018

Epidemiology and management of cryptococcal meningitis: developments and challenges

Read Pukkila-Worley1, Eleftherios Mylonakis

  • 1Massachusetts General Hospital, Division of Infectious Diseases, 55 Fruit Street, Boston, MA 02114-2696, USA.

Expert Opinion on Pharmacotherapy
|March 4, 2008
PubMed

Insights

Cryptococcal infections, caused by Cryptococcus neoformans and Cryptococcus gattii, pose significant global health challenges. Despite new treatments, cryptococcal meningitis mortality remains high, necessitating further research and improved management strategies.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Public Health

Background:

  • Cryptococcal infection has evolved in significance as a cause of human disease.
  • Cryptococcus neoformans var. grubii primarily affects immunocompromised individuals.
  • Cryptococcus gattii is increasingly recognized for infecting immunocompetent hosts, with recent outbreaks highlighting its emerging clinical importance.

Purpose of the Study:

  • To outline the global significance of cryptococcosis.
  • To review recent developments in managing cryptococcal meningitis.

Main Methods:

  • Literature review of cryptococcal infections and their management.
  • Analysis of disease trends and emerging pathogens.
  • Evaluation of current therapeutic strategies for cryptococcal meningitis.

Main Results:

  • Cryptococcus neoformans var. grubii remains a major pathogen in immunosuppressed populations.
  • Cryptococcus gattii outbreaks in new environments underscore its expanding clinical relevance.
  • New antifungal agents and intracranial pressure management strategies offer improved therapeutic options.

Conclusions:

  • Cryptococcal meningitis continues to present significant management challenges with unacceptably high mortality rates.
  • Further advancements in antifungal therapies and supportive care are crucial for improving patient outcomes.
  • Understanding the distinct epidemiology and clinical presentations of different Cryptococcus species is vital for effective disease control.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...